The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pemetrexed plus erlotinib as a salvage treatment in high EGFR-expressing metastatic colorectal cancer patients following failure of standard chemotherapy: A phase II single-arm prospective study.
 
Seonggyu Byeon
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Jung Yong Hong
No Relationships to Disclose
 
Jeeyun Lee
No Relationships to Disclose
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene
Research Funding - Celgene; Celgene; Celgene; Celgene
 
Ho-Yeong Lim
No Relationships to Disclose
 
Won Ki Kang
No Relationships to Disclose
 
Young Suk Park
No Relationships to Disclose